Protagonist Therapeutics PTGX Total Revenue
Total Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's total revenue?
- Protagonist Therapeutics (PTGX) reported total revenue of $56.37M in Q1 2026.
- How has Protagonist Therapeutics's total revenue changed year-over-year?
- Protagonist Therapeutics's total revenue increased by 99.0% year-over-year, from $28.32M to $56.37M.
- What is the long-term trend for Protagonist Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's total revenue has grown at a 13.9% compound annual growth rate (CAGR), from $27.36M to $46.02M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.